Register to receive a free US Cardiac Surgery and Heart Valve Device Market report synopsis and brochure
According to a new series of reports on the U.S. market for cardiac surgery and heart valve devices by iData Research, growth in the U.S. tissue heart valve market is primarily fueled by unit sales and a growing number of heart valve replacement procedures, as well as the continued shift in preference for tissue valves over mechanical valves. Technological improvements helping to increase durability of tissue valves have further helped to fuel growth.
The majority of tissue valve replacement procedures performed in the U.S. is for the aortic valve. Mitral valve replacements accounted for approximately 22% of all tissue valve procedures performed in 2015. The share of total tissue valve replacement procedures represented by mitral valves is expected to increase over the forecast period as the penetration rate of transcatheter aortic valve replacement procedures increases and the treatment of mitral valve defects shifts from repair to replacement.
The U.S. market for tissue heart valves is segmented by stented tissue heart valves and stentless tissue heart valves. The stentless valves have some inherent advantages over stented valves. Stentless valves better mimic the natural physiological functioning of heart valves, because absence of the stent allows for unimpeded, natural blood flow through the valve, reducing stress on the surrounding heart tissue and increasing the durability of the valve itself. Despite these benefits, the difficulty of the stentless valve implantation procedure is expected to cause this segment to decline over the forecast period. Growth in the unit sales of stented tissue heart valves is expected to propel an increase in the value of the stented tissue heart valve segment.
Most tissue heart valves use xenograft tissue. However, a small percentage of tissue heart valve unit sales are allograft valves. The unit sales of the allograft heart valves are limited by the availability of tissue donors.
“Tissue valve market growth is expected to decelerate over the forecast period as the market is reaching maturity,” explains Dr. Kamran Zamanian, CEO of iData. “The increasing penetration rate of transcatheter aortic valve implantation devices will also aid in decelerating the growth in unit sales of tissue heart valves.”
Edwards Lifesciences is the leading competitor in the U.S. market for tissue heart valves. Edwards Lifesciences offers a diverse tissue valve product line. The company’s best known products include the Carpentier-Edwards PERIMOUNT® line of pericardial derived tissue valves. Medtronic was the second leading competitor in the total tissue heart valve market and is notably the market leader in stentless valves. Most of the company’s stented tissue valve sales are attributed to its Mosaic® and Hancock® products. The company’s Freestyle® stentless valves also have a strong presence in the market.
St. Jude Medical, currently in the process of being acquired by Abbott Laboratories, is the third leading competitor and has traditionally focused on the mechanical valve market, in which it is the leader, but held a sizeable share of the tissue heart valve market. St. Jude formerly generated most of its tissue valve revenue from its Toronto SPV® stentless valve, but has discontinued that particular product and now derives most of its tissue valve sales from its Biocor® stented valve. Other notable competitors in the tissue heart valve market include CryoLife, Sorin Group and LifeNet Health among others.
For Further Information
More on the U.S. markets for cardiac surgery and heart valve devices can be found in the 2016 edition report published by iData entitled U.S. Markets for Cardiac Surgery and Heart Valve Devices, which covers market segments for the following: tissue heart valves, mechanical heart valves, annuloplasty repair, transcatheter mitral valve repair, transcatheter heart valve implantation, on-pump coronary artery bypass, off-pump coronary artery bypass, endoscopic vessel harvesting, anastomosis assist, cardiac ablation, transmyocardial revascularization, ventricular assist, intra-aortic balloon pumps, artifical hearts, patent foramen ovale, and atrial and ventricular septal devices.
Recent reports on the markets for cardiac surgery and heart valve devices cover the U.S. and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at [email protected] for a U.S. Markets for Cardiac Surgery and Heart Valve Devices report brochure and synopsis.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.